Antoine Meyer News Today

A large, prospective study provides data to guide clinicians who treat patients at high risk for Crohns disease.

There's more than meets the eye to Luxembourgish poetry, culture critic Tom Einarsson argues

Continuing anti-TNF therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of IBD in pregnant women and fewer premature deliveries, according to a new report.

Risk for maternal IBD relapse and prematurity reduced with continuation of anti-TNF after 24 weeks of pregnancy.

Study of IBD patients finds no basis for common practice